Astragaloside IV inhibits excessive mesangial cell proliferation and renal fibrosis caused by diabetic nephropathy via modulation of the TGF-β1/Smad/miR-192 signaling pathway

Astragaloside IV (ASI) exhibits a wide variety of pharmacological effects in cardiovascular diseases, hepatitis and kidney disease and due to this, ASI has recently become an attractive research target. The present study aimed to determine the effect of ASI on renal fibrosis and the mechanisms under...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Qian, Chen, Cuicui, Liang, Huankun, Zhong, Shuhai, Cheng, Xinbo, Li, Laiqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755437/
https://www.ncbi.nlm.nih.gov/pubmed/31572545
http://dx.doi.org/10.3892/etm.2019.7887

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755437/
https://www.ncbi.nlm.nih.gov/pubmed/31572545
http://dx.doi.org/10.3892/etm.2019.7887

Ejemplares similares